{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:07:34Z","timestamp":1769108854821,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The optimal management for cervical artery dissection (CAD) is uncertain. This study aimed to summarize the current randomized controlled trials (RCTs) to compare the efficacy and safety of antiplatelet and anticoagulation therapies for CAD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A literature search was conducted in the major databases, such as MEDLINE, Embase, and the Cochrane Library. Only the RCTs comparing the antiplatelet and anticoagulation therapies for the patients with CAD were included. Combined estimates of the relative risk (RR) of antiplatelet vs. anticoagulation were analyzed. Heterogeneity was measured using the <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> statistical analysis. The analyses were performed in the intention-to-treat (ITT) and per-protocol (PP) population, respectively.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Two RCTs involving 444 patients in the ITT population and 370 patients in the PP population were included. The quality of studies was high overall. In the ITT population, compared with the patients in the anticoagulation group, the patients in the antiplatelet group showed a higher rate of ischemic stroke within 3 months (<jats:italic>RR<\/jats:italic> = 6.73 [95% <jats:italic>CI<\/jats:italic>, 1.22\u201337.15], <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>P<\/jats:italic> = 0.029). No difference between these two treatment groups was found for the outcomes of transient ischemic attack (<jats:italic>RR<\/jats:italic> = 0.37 [95% <jats:italic>CI<\/jats:italic>, 0.09\u20131.58], <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>P<\/jats:italic> = 0.181), intracranial hemorrhage (<jats:italic>RR<\/jats:italic> = 0.33 [95% <jats:italic>CI<\/jats:italic>, 0.01\u20137.98], <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>P<\/jats:italic> = 0.494), major extracranial bleeding (<jats:italic>RR<\/jats:italic> = 0.31 [95% <jats:italic>CI<\/jats:italic>, 0.01\u20137.60], <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>P<\/jats:italic> = 0.476), or the composite of these outcomes within 3 months. For the PP population, the results of the meta-analysis of outcomes between the antiplatelet and anticoagulation groups were consistent with the ITT population.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Compared with the antiplatelet group, the anticoagulation group has a lower risk of ischemic stroke without increasing bleeding risk when treating CAD. Anticoagulation seems to be superior over the antiplatelet in treating CAD but needs to be further tested by specifying several issues, such as location, initial symptom types, and treatment protocols.<\/jats:p>","DOI":"10.3389\/fneur.2021.745106","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:44:09Z","timestamp":1638297849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Antiplatelet vs. Anticoagulation in Cervical Artery Dissection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Sihua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s1474-4422(09)70084-5","article-title":"Cervical-artery dissections: predisposing factors, diagnosis, and outcome","volume":"8","author":"Debette","year":"2009","journal-title":"The Lancet Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.thromres.2009.01.013","article-title":"Cervical artery dissection: pathology, epidemiology and management","volume":"123","author":"Kim","year":"2009","journal-title":"Thromb Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/jnnp.2009.192153","article-title":"Recurrent stroke after cervical artery dissection","volume":"81","author":"Weimar","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/01.STR.0000098649.39767.BC","article-title":"Cervical arterial dissection: time for a therapeutic trial?","volume":"34","author":"Beletsky","year":"2003","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/01.str.26.2.235","article-title":"Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients","volume":"26","author":"Biousse","year":"1995","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/01.str.27.7.1226","article-title":"Transcranial Doppler in the evaluation of internal carotid artery dissection","volume":"27","author":"Srinivasan","year":"1996","journal-title":"Stroke."},{"key":"B7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp.2007.127639","article-title":"Results of a UK questionnaire of diagnosis and treatment in cervical artery dissection","volume":"79","author":"Menon","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejvs.2015.04.034","article-title":"Antithrombotic treatment for acute extracranial carotid artery dissections: a meta-analysis","volume":"50","author":"Chowdhury","year":"2015","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e72697","DOI":"10.1371\/journal.pone.0072697","article-title":"Antiplatelets versus anticoagulants for the treatment of cervical artery dissection: Bayesian meta-analysis","volume":"8","author":"Sarikaya","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1212\/01.wnl.0000427910.00596.db","article-title":"Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis","volume":"80","author":"Caplan","year":"2013","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000255.pub2","article-title":"Antithrombotic drugs for carotid artery dissection","author":"Lyrer","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1136\/jnnp.2007.138800","article-title":"Treatment of cervical artery dissection: a systematic review and meta-analysis","volume":"79","author":"Menon","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jamaneurol.2019.0072","article-title":"Cervical Artery Dissection in Stroke Study I. antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: The cervical artery dissection in stroke study (CADISS) randomized clinical trial final results","volume":"76","author":"Markus","year":"2019","journal-title":"JAMA Neurol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00044-2","article-title":"Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial","author":"Engelter","year":"2021","journal-title":"The Lancet Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11065-016-9319-z","article-title":"A guide to conducting a meta-analysis","volume":"26","author":"Cheung","year":"2016","journal-title":"Neuropsychol Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1212\/WNL.0b013e3181a2a50a","article-title":"Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients","volume":"72","author":"Georgiadis","year":"2009","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/s1474-4422(14)70271-6","article-title":"a feasibility trial that answered its question","volume":"14","author":"Kasner","year":"2015","journal-title":"The Lancet Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10072-019-03882-8","article-title":"Rivaroxaban in cervical and \u201ccervico-cerebral\u201d artery dissections: a new therapeutic option?","volume":"40","author":"Malferrari","year":"2019","journal-title":"Neurol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijcard.2017.06.006","article-title":"Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature","volume":"244","author":"Cappellari","year":"2017","journal-title":"Int J Cardiol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.745106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:44:12Z","timestamp":1638297852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.745106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":22,"alternative-id":["10.3389\/fneur.2021.745106"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.745106","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"article-number":"745106"}}